Demographic and clinical characteristics | Patients (n = 272) | Pvalue* | Controls (n = 101) | Pvalue# | ||
---|---|---|---|---|---|---|
ET-PD (n = 15) | ET-only (n = 116) | PD-only (n = 141) | ||||
Age, y | 69 ± 9.6 | 63.9 ± 14.4 | 64.4 ± 11.2 | NS | 61.7 ± 12.4 | NS |
Gender (male) | 6 (40) | 39 (33.6) | 75 (53.2) | 0.007 | 56 (55.4) | 0.004 |
Sympt. duration y | 6 (3-15) | 5 (1-10) | 3 (1-6) | 0.003a | N/A | N/A |
Family history + | 8 (53.3) | 35 (31.3) | 23 (17) | 0.005 | 4 (4.3) | <0.001 |
Toxic exposure | 3 (20) | 19 (16.4) | 23 (16.3) | NS | 16 (15.8) | NS |
Living in rural | 4 (26.7) | 19 (16.4) | 29 (20.6) | NS | 16 (15.8) | NS |
Cogwheel sign | 4 (26.7) | 3 (2.6) | 129 (91.5) | <0.001 | 0 (0) | <0.001 |
Pyramidal signs | 2 (13.3) | 3 (2.6) | 19 (13.5) | 0.009 | 10 (9.9) | 0.025 |
H&Y stage | 2.6 ± 0.8 | N/A | 1.8 ± 0.8 | 0.012 | N/A | N/A |
UPDRS part I | 1 (0-1) | 1 (0-3) | 3 (1-4) | NS | N/A | N/A |
UPDRS part II | 5 (4-6) | 13 (12-13) | 11 (7-16) | NS | N/A | N/A |
UPDRS part III | 5 (3-6) | 4 (1-6) | 14 (9-20) | 0.021b | N/A | N/A |
HAD-Anxiety | 1 (1-8) | 6 (2-10) | 8 (5-11) | NS | 5 (3-8) | NS |
HAD-Depression | 4 (4-7) | 4 (2-6) | 6 (4-9) | NS | 3 (1-7) | NS |
SF36-PF | 53.3 ± 17.6 | 52.3 ± 31.8 | 45.9 ± 25.3 | NS | 70 ± 24.2 | 0.001c |
SF36-RLPF | 16.7 ± 28.9 | 33.1 ± 29 | 33.3 ± 27 | NS | 50.2 ± 29.4 | 0.020d |
SF36-RLEF | 33.3 ± 57.7 | 51.4 ± 30 | 40.8 ± 34.2 | NS | 59 ± 32.2 | NSe |
SF36-EF | 43.3 ± 10.4 | 43.8 ± 24.8 | 44.5 ± 19.4 | NS | 58.8 ± 17.1 | 0.007f |
SF36-EW | 66.7 ± 38.9 | 52.5 ± 26 | 53.7 ± 19.3 | NS | 64.7 ± 15.8 | NSg |
SF36-SF | 58.3 ± 19.1 | 57.3 ± 31.5 | 53.8 ± 24.9 | NS | 75.7 ± 46.7 | 0.050h |
SF36-P | 66.7 ± 18.8 | 65.7 ± 26.7 | 49.5 ± 30.7 | NS | 61.7 ± 28.2 | NS |
SF36-GH | 28.3 ± 2.9 | 35 ± 19.4 | 31.1 ± 16.9 | NS | 49.1 ± 18.5 | <0.001i |